123 related articles for article (PubMed ID: 8639845)
1. In vitro antioxidant treatment recovers proliferative responses of anergic CD4+ lymphocytes from human immunodeficiency virus-infected individuals.
Cayota A; Vuillier F; Gonzalez G; Dighiero G
Blood; 1996 Jun; 87(11):4746-53. PubMed ID: 8639845
[TBL] [Abstract][Full Text] [Related]
2. Virological and immunological effects of antioxidant treatment in patients with HIV infection.
Müller F; Svardal AM; Nordoy I; Berge RK; Aukrust P; Frøland SS
Eur J Clin Invest; 2000 Oct; 30(10):905-14. PubMed ID: 11029606
[TBL] [Abstract][Full Text] [Related]
3. Modulation of LPS-induced CD4+ T-cell activation and apoptosis by antioxidants in untreated asymptomatic HIV infected participants: an in vitro study.
Mburu S; Marnewick JL; Abayomi A; Ipp H
Clin Dev Immunol; 2013; 2013():631063. PubMed ID: 24348678
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids rescue CD4+ T lymphocytes from activation-induced apoptosis triggered by HIV-1: implications for pathogenesis and therapy.
Lu W; Salerno-Goncalves R; Yuan J; Sylvie D; Han DS; Andrieu JM
AIDS; 1995 Jan; 9(1):35-42. PubMed ID: 7893439
[TBL] [Abstract][Full Text] [Related]
5. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.
Resino S; Abad ML; Navarro J; Bellón JM; Sánchez-Ramón S; Angeles Muñoz-Fernández M
Clin Exp Immunol; 2003 Jan; 131(1):130-7. PubMed ID: 12519396
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.
Bouhdoud L; Villain P; Merzouki A; Arella M; Couture C
J Virol; 2000 Mar; 74(5):2121-30. PubMed ID: 10666241
[TBL] [Abstract][Full Text] [Related]
7. Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV replication in monocytes and interleukin 2-induced lymphocyte proliferation.
Aillet F; Gougerot-Pocidalo MA; Virelizier JL; Israël N
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):405-11. PubMed ID: 7915123
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo.
Sloand EM; Kumar PN; Kim S; Chaudhuri A; Weichold FF; Young NS
Blood; 1999 Aug; 94(3):1021-7. PubMed ID: 10419894
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection.
Aukrust P; Svardal AM; Müller F; Lunden B; Berge RK; Ueland PM; Frøland SS
Blood; 1995 Jul; 86(1):258-67. PubMed ID: 7795231
[TBL] [Abstract][Full Text] [Related]
10. CD4+ lymphocytes from HIV-infected patients display impaired CD45-associated tyrosine phosphatase activity which is enhanced by anti-oxidants.
Cayota A; Vuillier F; Gonzalez G; Dighiero G
Clin Exp Immunol; 1996 Apr; 104(1):11-7. PubMed ID: 8603515
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes.
Zauli G; Gibellini D; Celeghini C; Mischiati C; Bassini A; La Placa M; Capitani S
J Immunol; 1996 Sep; 157(5):2216-24. PubMed ID: 8757349
[TBL] [Abstract][Full Text] [Related]
12. Defective protein tyrosine phosphorylation and altered levels of p59fyn and p56lck in CD4 T cells from HIV-1 infected patients.
Cayota A; Vuillier F; Siciliano J; Dighiero G
Int Immunol; 1994 Apr; 6(4):611-21. PubMed ID: 7912546
[TBL] [Abstract][Full Text] [Related]
13. CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness.
Dybul M; Mercier G; Belson M; Hallahan CW; Liu S; Perry C; Herpin B; Ehler L; Davey RT; Metcalf JA; Mican JM; Seder RA; Fauci AS
J Immunol; 2000 Aug; 165(3):1685-91. PubMed ID: 10903780
[TBL] [Abstract][Full Text] [Related]
14. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.
Sousa AE; Carneiro J; Meier-Schellersheim M; Grossman Z; Victorino RM
J Immunol; 2002 Sep; 169(6):3400-6. PubMed ID: 12218162
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children.
Scott ZA; Beaumier CM; Sharkey M; Stevenson M; Luzuriaga K
J Immunol; 2003 Jun; 170(11):5786-92. PubMed ID: 12759463
[TBL] [Abstract][Full Text] [Related]
16. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention.
Leng Q; Bentwich Z; Magen E; Kalinkovich A; Borkow G
AIDS; 2002 Mar; 16(4):519-29. PubMed ID: 11872994
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
Yamamura Y; Rodriguez N; Schwartz A; Eylar E; Yano N
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S133-44. PubMed ID: 8574141
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells.
Wang L; Klimpel GR; Planas JM; Li H; Cloyd MW
Virology; 1998 Feb; 241(2):169-80. PubMed ID: 9499792
[TBL] [Abstract][Full Text] [Related]
20. Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants.
Aukrust P; Müller F; Svardal AM; Ueland T; Berge RK; Frøland SS
J Infect Dis; 2003 Jul; 188(2):232-8. PubMed ID: 12854078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
